CCR2 and arthritic joint disease: In fact, in K/BxN STIA, although systemic clodronate-mediated depletion of macrophages resulted in a drastic amelioration of the arthritis (53, 54), CCR2 deficiency (54) did not alter arthritis development whereas CX3CR1 deficiency produced exacerbated inflammation (16, 17).